J.P. Gabriel

Directeur Technique/Scientifique/R&D chez SILENCE THERAPEUTICS PLC

Health Technology

Commercial Services

Consumer Services

Profil

John Paul Gabriel is currently Chief Technical Operations Officer at Silence Therapeutics Plc since 2022.
Formerly, Mr. Gabriel was Senior Vice President-Technical Operations at Ocugen, Inc. from 2021 to 2022 and Vice President-Biologics & mRNA Manufacturing at Ultragenyx Pharmaceutical, Inc. Education includes an undergraduate degree from the University of Guelph.

Postes actifs de J.P. Gabriel

Sociétés	Poste	Début
SILENCE THERAPEUTICS PLC	Directeur Technique/Scientifique/R&D	01/11/2022

Tous les postes actifs de J.P. Gabriel

Anciens postes connus de J.P. Gabriel

Sociétés	Poste	Fin
OCUGEN, INC.	Corporate Officer/Principal	01/09/2022
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	-

Voir l'expérience en détail de J.P. Gabriel

Formation de J.P. Gabriel

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de J.P. Gabriel

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases	Health Technology
Silence Therapeutics Plc Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products	Commercial Services
University of Guelph University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ocugen, Inc. Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products	Health Technology